Frontiers in Pharmacology (Apr 2022)

BI 1015550 is a PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis

  • Franziska Elena Herrmann,
  • Christian Hesslinger,
  • Lutz Wollin,
  • Peter Nickolaus

DOI
https://doi.org/10.3389/fphar.2022.838449
Journal volume & issue
Vol. 13

Abstract

Read online

Graphical Abstract

Keywords